XML 13 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning Balance at May. 31, 2022 $ 887,374 $ 17,248 $ 309,984 $ (27,769) $ 587,911
Beginning Balance (in shares) at May. 31, 2022   107,801,094      
Exercise of options and share-based compensation expense 1,905 $ 1 1,904    
Exercise of options and share-based compensation expense (in shares)   4,000      
Issuance of shares under employee stock purchase plan 867 $ 5 862    
Issuance of shares under employee stock purchase plan (in shares)   32,636      
Net income (loss) 5,209       5,209
Other comprehensive income (loss) (11,557)     (11,557)  
Ending Balance at Aug. 31, 2022 883,798 $ 17,254 312,750 (39,326) 593,120
Ending Balance (in shares) at Aug. 31, 2022   107,837,730      
Beginning Balance at May. 31, 2022 887,374 $ 17,248 309,984 (27,769) 587,911
Beginning Balance (in shares) at May. 31, 2022   107,801,094      
Net income (loss) (28,442)        
Other comprehensive income (loss) (5,453)        
Ending Balance at Feb. 28, 2023 3,125,555 $ 34,595 2,564,713 (33,222) 559,469
Ending Balance (in shares) at Feb. 28, 2023   216,220,821      
Beginning Balance at Aug. 31, 2022 883,798 $ 17,254 312,750 (39,326) 593,120
Beginning Balance (in shares) at Aug. 31, 2022   107,837,730      
Exercise of options and share-based compensation expense 2,637 $ 7 2,630    
Exercise of options and share-based compensation expense (in shares)   46,607      
Issuance of shares for 3M transaction (Value) 2,262,841 $ 17,323 2,245,518    
Issuance of shares for 3M transaction (shares)   108,269,946      
Net income (loss) (41,841)       (41,841)
Other comprehensive income (loss) (1,172)     (1,172)  
Ending Balance at Nov. 30, 2022 3,106,263 $ 34,584 2,560,898 (40,498) 551,279
Ending Balance (in shares) at Nov. 30, 2022   216,154,283      
Exercise of options and share-based compensation expense 2,835 $ 1 2,834    
Exercise of options and share-based compensation expense (in shares)   4,570      
Issuance of shares under employee stock purchase plan 991 $ 10 981    
Issuance of shares under employee stock purchase plan (in shares)   61,968      
Net income (loss) 8,190       8,190
Other comprehensive income (loss) 7,276     7,276  
Ending Balance at Feb. 28, 2023 3,125,555 $ 34,595 2,564,713 (33,222) 559,469
Ending Balance (in shares) at Feb. 28, 2023   216,220,821      
Beginning Balance at May. 31, 2023 $ 3,134,217 $ 34,599 2,567,828 (33,251) 565,041
Beginning Balance (in shares) at May. 31, 2023 216,245,501 216,245,501      
Exercise of options and share-based compensation expense $ 2,661   2,661    
Exercise of options and share-based compensation expense (in shares)   2,591      
Issuance of shares under employee stock purchase plan 1,039 $ 11 1,028    
Issuance of shares under employee stock purchase plan (in shares)   62,490      
Net income (loss) 1,503       1,503
Other comprehensive income (loss) 6,755     6,755  
Ending Balance at Aug. 31, 2023 3,146,175 $ 34,610 2,571,517 (26,496) 566,544
Ending Balance (in shares) at Aug. 31, 2023   216,310,582      
Beginning Balance at May. 31, 2023 $ 3,134,217 $ 34,599 2,567,828 (33,251) 565,041
Beginning Balance (in shares) at May. 31, 2023 216,245,501 216,245,501      
Net income (loss) $ (4,006)        
Other comprehensive income (loss) 3,778        
Ending Balance at Feb. 29, 2024 $ 3,146,174 $ 34,657 2,579,955 (29,473) 561,035
Ending Balance (in shares) at Feb. 29, 2024 216,607,746 216,607,746      
Beginning Balance at Aug. 31, 2023 $ 3,146,175 $ 34,610 2,571,517 (26,496) 566,544
Beginning Balance (in shares) at Aug. 31, 2023   216,310,582      
Exercise of options and share-based compensation expense 3,511 $ 34 3,477    
Exercise of options and share-based compensation expense (in shares)   209,714      
Net income (loss) (3,487)       (3,487)
Other comprehensive income (loss) 1,368     1,368  
Ending Balance at Nov. 30, 2023 3,147,567 $ 34,644 2,574,994 (25,128) 563,057
Ending Balance (in shares) at Nov. 30, 2023   216,520,296      
Exercise of options and share-based compensation expense 3,751 $ 2 3,749    
Exercise of options and share-based compensation expense (in shares)   15,130      
Issuance of shares under employee stock purchase plan 1,223 $ 11 1,212    
Issuance of shares under employee stock purchase plan (in shares)   72,320      
Net income (loss) (2,022)       (2,022)
Other comprehensive income (loss) (4,345)     (4,345)  
Ending Balance at Feb. 29, 2024 $ 3,146,174 $ 34,657 $ 2,579,955 $ (29,473) $ 561,035
Ending Balance (in shares) at Feb. 29, 2024 216,607,746 216,607,746